BMC medicine
The efficacy and safety of duloxetine in treating refractory chronic cough: a randomized clinical trial.
Shengyuan Wang, Heng Wu, Yaxing Zhou, Wanzhen Li, Tongyangzi Zhang, Cuiqin Shi, Li Yu, Xianghuai Xu
Published: 202610.1186/s12916-025-04613-x
Abstract
BACKGROUND: Enhanced cough sensitivity is proposed as a potential cause for refractory chronic cough (RCC), and modulation of sensory nerve hyperresponsiveness is suggested as an effective treatment. However, the treatment of RCC has considerable pot…
Preview only. Read the full abstract at the source